[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@DalvinVarnado Avatar @DalvinVarnado Dalvin Varnado

Dalvin Varnado posts on X about $nvct, $lly, $axsm, $mrk the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

Mentions: X #

Mentions Line Chart

Followers: XXXXXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #

Social category influence stocks

Social topic influence $nvct #1, $lly, $axsm, $mrk, $kymr, $rvmd, $pfe, imo

Top assets mentioned Eli Lilly and Company (LLY) Axsome Therapeutics, Inc (AXSM) Merck & Co., Inc. (MRK) Kymera Therapeutics, Inc. Common Stock (KYMR) Revolution Medicines, Inc. Common Stock (RVMD) Pfizer, Inc. (PFE)

Top Social Posts #

Top posts by engagements in the last XX hours

"$NVCT major upside surprise coming. Predicting little talked about NXP800 with fast track status advancing to phase X with much better than expected trial data Recent insider buying what else can I say $AXSM $LLY $KYMR $RVMD $MRK"
@DalvinVarnado Avatar @DalvinVarnado on X 2025-07-10 13:39:05 UTC 27.8K followers, 1575 engagements

"$NVCT delayed data NXP800 ongoing. Opposite universal low expectations Im expecting major rising stock price with data release showing tumor shrinkage 75mg intermittent dosing. Sets up free-roll on NXP900 a drug many investors think has blockbuster potential $AXSM $LLY $MRK $PFE"
@DalvinVarnado Avatar @DalvinVarnado on X 2025-07-23 14:39:36 UTC 27.9K followers, 1203 engagements

"@JD4for4 $NVCT company said recent offering Feb XX provided runway into 2027. Was my opinion company would go back to market at higher price after XXX data. Recent insider buying and and now imo company letting someone close get a great entry price before XXX data. JUST THAT SIMPLE imo"
@DalvinVarnado Avatar @DalvinVarnado on X 2025-07-25 13:17:00 UTC 27.9K followers, XXX engagements

"@VeracityRoad Yes during Nov XX update CEO said trial was currently enrolling last cohort of patients and would provide update during Q2. More recently about X months ago CEO pushed out timeline X months so data release is any day now past original timeline of Q2"
@DalvinVarnado Avatar @DalvinVarnado on X 2025-07-23 17:21:03 UTC 27.9K followers, XX engagements